Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Use of complement pathway inhibitors to treat ocular diseases

No-Receipt date 2018-03568 - 08/10/2018
No-Filing date 20180402846 - 08/10/2018
No-Granting date 3086850.B2 - 23/11/2018
No-EPO application date 12172001.5 - 04/11/2006
No-EPO granting date 2500030 - 08/08/2018
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 11/2018 - 25/02/2019
Expiration date 05/11/2026
Kind of title Amended European Patent Validation
Legal status NOT VALID
Priorities US733763 P04/11/2005/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/00
A61K 39/00
A61K 39/395
A61K 48/00
C07K 16/18
C07K 17/00

Related Documents

Related Titles
TypeMaster titleRelated title
[ADD] 20150401790

Owners
CodeFirstnameSurnameAddressTownZIPCountry
932279 GENENTECH, INC. 1 DNA WAYSOUTH SAN FRANCISCO, CA 94080-4990 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
2327019 FUNG, SEK CHUNG
2327020 YAO, ZHENGBIN

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
6/9/2020 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 05/2020 Αρ. Πρωτ. ΓΔ 961 / 09-06-2020

Payments history 13 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015